UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027257
Receipt number R000031223
Scientific Title The assessment of synergistic effect of STFX and a-PDT to MRONJ
Date of disclosure of the study information 2017/05/08
Last modified on 2019/06/02 09:27:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The assessment of synergistic effect of STFX and a-PDT to MRONJ

Acronym

synergistic effect of STFX and a-PDT to MRONJ

Scientific Title

The assessment of synergistic effect of STFX and a-PDT to MRONJ

Scientific Title:Acronym

synergistic effect of STFX and a-PDT to MRONJ

Region

Japan


Condition

Condition

MRONJ

Classification by specialty

Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the treatment effect of STFX and a-PDT for MRONJ.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the term until improvement of symptoms of infection.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

STFX 100mg/day 4weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

MRONJ

Key exclusion criteria

hepatic or kidney disoeder
allergy
pregnant

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Seigo
Middle name
Last name Ohba

Organization

Nagasaki University

Division name

Regenerative Oral Surgery

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7704

Email

sohba@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Seigo
Middle name
Last name Ohba

Organization

Nagasaki Uiversity

Division name

Regenerative Oral Surgery

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7704

Homepage URL


Email

sohba@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University

Address

1-7-1 Sakamoto, Nagasaki

Tel

096-819-7704

Email

sohba@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results

Only 2 patients who underwent this protocol treatment, were followed up and the progress of both of them was good.

Results date posted

2019 Year 06 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 07 Month 01 Day

Date of IRB

2015 Year 07 Month 01 Day

Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date

2017 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

These 2 case reports would be published in near future.


Management information

Registered date

2017 Year 05 Month 06 Day

Last modified on

2019 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031223